In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

BACKGROUND: Previous studies have reported conflicting results for the comparative doses of recombinant follicle stimulating hormone (rFSH) and highly purified human menopausal gonadotrophin (hMG-HP) required per cycle of in vitro fertilisation (IVF); the aim of this study was to determine the avera...

Descripción completa

Detalles Bibliográficos
Autores principales: Trew, Geoffrey H, Brown, Adam P, Gillard, Samantha, Blackmore, Stuart, Clewlow, Christine, O'Donohoe, Paul, Wasiak, Radoslaw
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993713/
https://www.ncbi.nlm.nih.gov/pubmed/21059191
http://dx.doi.org/10.1186/1477-7827-8-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993713/
https://www.ncbi.nlm.nih.gov/pubmed/21059191
http://dx.doi.org/10.1186/1477-7827-8-137

Ejemplares similares